21 – 30 of 176
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Kloka kliniska val och hälsoekonomiska utvärderingar
(2025) In Läkartidningen
- Contribution to journal › Debate/Note/Editorial
- 2024
-
Mark
Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
- Contribution to journal › Scientific review
-
Mark
Molecular Subtypes Are Associated With Clinical Benefit in Cisplatin-Treated Metastatic Urothelial Cancer Patients
- Contribution to journal › Article
-
Mark
Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations
- Contribution to journal › Article
-
Mark
Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostat-ectomy. A nationwide population-based study
- Contribution to journal › Article
-
Mark
Tumour immune characterisation of primary triple-negative breast cancer using automated image quantification of immunohistochemistry-stained immune cells
- Contribution to journal › Article
-
Mark
The difficulty of studying the association between pathway delays and survival in cancer - an example from bladder cancer
- Contribution to journal › Debate/Note/Editorial
-
Mark
Diagnostic pathways and treatment strategies in upper tract urothelial carcinoma in Sweden between 2015 and 2021 : a population-based survey
- Contribution to journal › Article
-
Mark
Cystectomy for bladder cancer in Sweden - short-term outcomes after centralization
- Contribution to journal › Article
